T32 Pediatric Clinical and Developmental Pharmacology Training Network (PCDPTN)
BPCA legislation mandates the training of experts in pediatric pharmacology research. Since 2012, the BPCA program includes a T32 PCDPTN institutional research training grant program to help ensure that a diverse and highly trained workforce is available in an area that currently has a limited number of researchers. Without an increase in the pool of investigators trained in new "-omics" technologies and their application to pediatric therapeutics, integration and synergistic interaction will not be possible, and the overall goal of personalized pediatric therapeutics will not be realized.
This collaborative network allows interdisciplinary collaboration of clinical, translational, and basic investigators who research pediatric therapeutics.
Goals of the PCDPTN are to:
- Provide training in pediatric clinical pharmacology
- Stimulate interdisciplinary collaboration among clinical, translational, and basic researchers in pediatric therapeutics
- Enable the development of a pediatric pharmacology section within the adult clinical pharmacology department
Since the program’s inception, more than 100 participants have graduated from the T32 training programs. An annual meeting provides an opportunity for fellows to meet other trainees in the program, learn about research at other institutions, and access presentations by experts in the field and fellow trainees.